Image

ENGAGE | CONNECT | LEARN

4.5 hours of CME/CE credits and ABIM and ABPath MOC points for the entire care team

Why Attend?

Join experts from the multidisciplinary cancer team and connect with peers in your community to discover the latest innovations in metastatic colorectal cancer. From diagnosis to treatment, if you are involved in the care of patients with metastatic colorectal cancer, you have to be there.

You'll have the opportunity to participate in multiple activities, including:
  • A multidisciplinary interactive tumor board panel ready to lead you through challenging cases
  • Breakout sessions that allow for one-on-one time with faculty
  • Guidance on patient counseling and shared decision-making

CME Information

Agenda

Tumor Board with Expert Faculty Panel–90 minutes

Breakout Sessions–90 minutes

  • Biomarker Testing: Guidelines and Challenges
  • Strategies to Optimize mCRC Treatment Selection
  • Patient Counseling

Problem-based Learning Tabletop Exercise of mCRC Patient Cases–60 minutes

Action Plans Development and Summary Report Outs–30 minutes

Detroit and Virtual
Saturday 12.9.23

Register for COMBINED meeting in Detroit, Michigan
9:00 AM-1:30 PM ET

Why Attend

Join oncology experts and connect with learners in your community to discover the latest innovations in biomarker testing. If you're involved in the study, diagnosis, and treatment of patients with metastatic colorectal cancer, you have to be here.

You'll have the opportunity to paricipate in multiple activities, including:
  • A multidisciplinary molecular-based tumor board panel ready to lead you through challenging cases
  • Breakout sessions delving into biomarker testing guidelines, challenges, and treatment selection
  • Guidance on patient counseling and shared decision-making

Houston
September 22

Register for COMBINED meeting on September 23, 2023 in Houston, Texas

Detroit
December 9

Register for COMBINED meeting on December 9 in Detroit

CME Information

Agenda

Tumor Board with Expert Faculty Panel–90 minutes

Breakout Sessions–90 minutes

  • Biomarker Testing: Guidelines and Challenges
  • Linking Biomarkers to mCRC Treatment Selection
  • Patient Counseling

Problem-based Learning Tabletop Exercise of mCRC Patient Cases–60 minutes

Action Plans Development and Summary Report Outs–30 minutes

Faculty Presenters

Tim Cannon, MD
Sheridan Director
Molecular Tumor Board
Co-Director of the Gastrointestinal Cancer Program
Inova Schar Cancer Institute
Fairfax, Virginia

Wei Jiang, MD, PhD
Associate Professor
Director, Translational Research/Pathology Shared Resource of Sidney Kimmel Cancer Center
Thomas Jefferson University
Philadelphia, Pennsylvania

Benjamin Swanson, MD, PhD Associate Professor
Associate Director
Gastrointestinal Pathology Fellowship
University of Nebraska Medical Center
Omaha, Nebraska

Frank dela Rama, RN, MS, AOCNS
Clinical Nurse Specialist
Oncology/Genomics
Sutter Health, Palo Alto Foundation
Mountain View, California

Antonia Sepulveda, MD, PhD
Department of Pathology
Ralph E. Lowey Professor of Oncology
George Washington University (GW) School of Medicine and Health Sciences
Washington, D.C.

Manish Shah, MD
Chief, Solid Tumor Oncology
Weill Cornell Medicine
New York, New York

Philip A. Philip, MD, PhD
Professor of Oncology and Pharmacology
Leader, GI & Neuroendocrine Oncology
Medical Director, Cancer Clinical Trials
Chair, GI Cancer, SWOG
Henry Ford Cancer Institute
Wayne State University
Detroit, Michigan

This CME/CE event is presented in collaboration with the following organizations:

ACCC/ASCP/TFF logos

The France Foundation

A ACCME Accredited provider.

The France Foundation ©

Chandler Building, 84 Lyme Street, Old Lyme, CT USA